Literature DB >> 21111238

Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue.

Gilad Doitsh1, Marielle Cavrois, Kara G Lassen, Orlando Zepeda, Zhiyuan Yang, Mario L Santiago, Andrew M Hebbeler, Warner C Greene.   

Abstract

The mechanism by which CD4 T cells are depleted in HIV-infected hosts remains poorly understood. In ex vivo cultures of human tonsil tissue, CD4 T cells undergo a pronounced cytopathic response following HIV infection. Strikingly, >95% of these dying cells are not productively infected but instead correspond to bystander cells. We now show that the death of these "bystander" cells involves abortive HIV infection. Inhibitors blocking HIV entry or early steps of reverse transcription prevent CD4 T cell death while inhibition of later events in the viral life cycle does not. We demonstrate that the nonpermissive state exhibited by the majority of resting CD4 tonsil T cells leads to accumulation of incomplete reverse transcripts. These cytoplasmic nucleic acids activate a host defense program that elicits a coordinated proapoptotic and proinflammatory response involving caspase-3 and caspase-1 activation. While this response likely evolved to protect the host, it centrally contributes to the immunopathogenic effects of HIV.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21111238      PMCID: PMC3026834          DOI: 10.1016/j.cell.2010.11.001

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  42 in total

1.  HIV-1 actively replicates in naive CD4(+) T cells residing within human lymphoid tissues.

Authors:  D A Eckstein; M L Penn; Y D Korin; D D Scripture-Adams; J A Zack; J F Kreisberg; M Roederer; M P Sherman; P S Chin; M A Goldsmith
Journal:  Immunity       Date:  2001-10       Impact factor: 31.745

2.  A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes.

Authors:  Marielle Cavrois; Carlos De Noronha; Warner C Greene
Journal:  Nat Biotechnol       Date:  2002-09-30       Impact factor: 54.908

3.  Long HIV type 1 reverse transcripts can accumulate stably within resting CD4+ T cells while short ones are degraded.

Authors:  William J Swiggard; Una O'Doherty; David McGain; Deepa Jeyakumar; Michael H Malim
Journal:  AIDS Res Hum Retroviruses       Date:  2004-03       Impact factor: 2.205

4.  Dynamics of HIV-1 recombination in its natural target cells.

Authors:  David N Levy; Grace M Aldrovandi; Olaf Kutsch; George M Shaw
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-09       Impact factor: 11.205

5.  Bystander CD4+ T lymphocytes survive in HIV-infected human lymphoid tissue.

Authors:  Jean-Charles Grivel; Angelique Biancotto; Yoshinori Ito; Rosangela G Lima; Leonid B Margolis
Journal:  AIDS Res Hum Retroviruses       Date:  2003-03       Impact factor: 2.205

6.  HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy.

Authors:  B A Larder; G Darby; D D Richman
Journal:  Science       Date:  1989-03-31       Impact factor: 47.728

7.  Emergence of a drug-dependent human immunodeficiency virus type 1 variant during therapy with the T20 fusion inhibitor.

Authors:  Chris E Baldwin; Rogier W Sanders; Yiqun Deng; Suzanne Jurriaans; Joep M Lange; Min Lu; Ben Berkhout
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

8.  In vivo evolution of human immunodeficiency virus type 1 toward increased pathogenicity through CXCR4-mediated killing of uninfected CD4 T cells.

Authors:  Andreas Jekle; Oliver T Keppler; Erik De Clercq; Dominique Schols; Mark Weinstein; Mark A Goldsmith
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

9.  Apoptosis of bystander T cells induced by human immunodeficiency virus type 1 with increased envelope/receptor affinity and coreceptor binding site exposure.

Authors:  Geoffrey H Holm; Chengsheng Zhang; Paul R Gorry; Keith Peden; Dominique Schols; Erik De Clercq; Dana Gabuzda
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

10.  Coupling of human immunodeficiency virus type 1 fusion to virion maturation: a novel role of the gp41 cytoplasmic tail.

Authors:  Donald J Wyma; Jiyang Jiang; Jiong Shi; Jing Zhou; Janet E Lineberger; Michael D Miller; Christopher Aiken
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

View more
  223 in total

Review 1.  HIV reservoirs and strategies for eradication.

Authors:  Miranda Z Smith; Fiona Wightman; Sharon R Lewin
Journal:  Curr HIV/AIDS Rep       Date:  2012-03       Impact factor: 5.071

2.  Vpu-deficient HIV strains stimulate innate immune signaling responses in target cells.

Authors:  Brian P Doehle; Kristina Chang; Lamar Fleming; John McNevin; Florian Hladik; M Juliana McElrath; Michael Gale
Journal:  J Virol       Date:  2012-05-30       Impact factor: 5.103

3.  p38 Mitogen-activated protein kinase/signal transducer and activator of transcription-3 pathway signaling regulates expression of inhibitory molecules in T cells activated by HIV-1-exposed dendritic cells.

Authors:  Karlhans Fru Che; Esaki Muthu Shankar; Sundaram Muthu; Sasan Zandi; Mikael Sigvardsson; Jorma Hinkula; Davorka Messmer; Marie Larsson
Journal:  Mol Med       Date:  2012-10-24       Impact factor: 6.354

4.  Reading the fine print: sequence-specific activation of cGAS.

Authors:  Jessica J Chiang; Michaela U Gack
Journal:  Nat Immunol       Date:  2015-10       Impact factor: 25.606

Review 5.  Friend or Foe: Innate Sensing of HIV in the Female Reproductive Tract.

Authors:  Nadia R Roan; Martin R Jakobsen
Journal:  Curr HIV/AIDS Rep       Date:  2016-02       Impact factor: 5.071

Review 6.  Innate antiviral immune signaling, viral evasion and modulation by HIV-1.

Authors:  Arjun Rustagi; Michael Gale
Journal:  J Mol Biol       Date:  2013-12-08       Impact factor: 5.469

7.  Late-emerging strains of HIV induce T-cell homeostasis failure by promoting bystander cell death and immune exhaustion in naïve CD4 and all CD8 T-cells.

Authors:  Catherine N Kibirige; Frederick A Menendez; Hao Zhang; Tricia L Nilles; Susan Langan; Joseph B Margolick
Journal:  Med Hypotheses       Date:  2014-04-13       Impact factor: 1.538

8.  Protection afforded by an HIV vaccine candidate in macaques depends on the dose of SIVmac251 at challenge exposure.

Authors:  Monica Vaccari; Brandon F Keele; Steven E Bosinger; Melvin N Doster; Zhong-Min Ma; Justin Pollara; Anna Hryniewicz; Guido Ferrari; Yongjun Guan; Donald N Forthal; David Venzon; Claudio Fenizia; Tia Morgan; David Montefiori; Jeffrey D Lifson; Chris J Miller; Guido Silvestri; Margherita Rosati; Barbara K Felber; George N Pavlakis; James Tartaglia; Genoveffa Franchini
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

9.  The anti-caspase inhibitor Q-VD-OPH prevents AIDS disease progression in SIV-infected rhesus macaques.

Authors:  Mireille Laforge; Ricardo Silvestre; Vasco Rodrigues; Julie Garibal; Laure Campillo-Gimenez; Shahul Mouhamad; Valérie Monceaux; Marie-Christine Cumont; Henintsoa Rabezanahary; Alain Pruvost; Anabela Cordeiro-da-Silva; Bruno Hurtrel; Guido Silvestri; Anna Senik; Jérôme Estaquier
Journal:  J Clin Invest       Date:  2018-03-19       Impact factor: 14.808

Review 10.  HIV cell-to-cell transmission: effects on pathogenesis and antiretroviral therapy.

Authors:  Luis M Agosto; Pradeep D Uchil; Walther Mothes
Journal:  Trends Microbiol       Date:  2015-03-09       Impact factor: 17.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.